NYSE:MED Medifast (MED) Stock Price, News & Analysis $13.18 +0.68 (+5.44%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Medifast Stock (NYSE:MED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medifast alerts:Sign Up Key Stats Today's Range$12.35▼$13.2750-Day Range$11.93▼$15.0652-Week Range$11.57▼$29.63Volume277,973 shsAverage Volume318,306 shsMarket Capitalization$144.16 millionP/E Ratio73.22Dividend YieldN/APrice Target$16.50Consensus RatingHold Company OverviewMedifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More… Medifast Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreMED MarketRank™: Medifast scored higher than 77% of companies evaluated by MarketBeat, and ranked 59th out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days.Read more about Medifast's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth200.00% Earnings GrowthEarnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 73.22, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 73.22, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 15.50.Price to Book Value per Share RatioMedifast has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted11.45% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Medifast has recently decreased by 13.04%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Medifast is 3,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, Medifast will have a dividend payout ratio of 431.37% in the coming year. This indicates that Medifast may not be able to sustain their current dividend.Read more about Medifast's dividend. Sustainability and ESG2.0 / 5Environmental Score-4.00 Percentage of Shares Shorted11.45% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Medifast has recently decreased by 13.04%, indicating that investor sentiment is improving significantly. News and Social Media1.1 / 5News Sentiment-0.02 News SentimentMedifast has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Medifast this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Stock News HeadlinesMedifast’s Earnings Call: Mixed Sentiment Amid ChallengesApril 29 at 8:34 PM | tipranks.comMedifast, Inc. (NYSE:MED) Q1 2025 Earnings Call TranscriptApril 29 at 1:26 PM | msn.comThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.April 30, 2025 | Weiss Ratings (Ad)Q1 2025 Medifast Inc Earnings CallApril 29 at 8:24 AM | finance.yahoo.comMedifast Q1 2025 slides: Adapting strategy for GLP-1 era amid revenue challengesApril 29 at 3:39 AM | investing.comMedifast shares drop as revenue misses estimates, guidance disappointsApril 29 at 3:23 AM | investing.comMedifast Announces First Quarter 2025 Financial ResultsApril 29 at 3:23 AM | finance.yahoo.comMedifast Inc (MED) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic FocusApril 29 at 3:23 AM | uk.finance.yahoo.comSee More Headlines MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? Medifast's stock was trading at $17.62 at the start of the year. Since then, MED shares have decreased by 25.2% and is now trading at $13.18. View the best growth stocks for 2025 here. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) posted its quarterly earnings results on Monday, April, 28th. The specialty retailer reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by $0.04. The specialty retailer had revenue of $115.73 million for the quarter, compared to analyst estimates of $114.85 million. Medifast had a net margin of 0.35% and a trailing twelve-month return on equity of 10.64%. Read the conference call transcript. Who are Medifast's major shareholders? Medifast's top institutional shareholders include Peapod Lane Capital LLC (0.63%), Values First Advisors Inc. (0.59%), Bank of New York Mellon Corp (0.45%) and SummerHaven Investment Management LLC (0.38%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY). Company Calendar Last Earnings4/28/2025Today4/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$16.50 High Stock Price Target$16.50 Low Stock Price Target$16.50 Potential Upside/Downside+25.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.18 Trailing P/E Ratio73.22 Forward P/E Ratio25.84 P/E GrowthN/ANet Income$99.42 million Net Margins0.35% Pretax Margin0.63% Return on Equity10.64% Return on Assets7.57% Debt Debt-to-Equity RatioN/A Current Ratio3.34 Quick Ratio2.55 Sales & Book Value Annual Sales$602.46 million Price / Sales0.24 Cash Flow$2.70 per share Price / Cash Flow4.88 Book Value$19.21 per share Price / Book0.69Miscellaneous Outstanding Shares10,938,000Free Float10,665,000Market Cap$144.16 million OptionableOptionable Beta1.05 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSE:MED) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.